IQVIA™ Real-World Insights Bibliography

Ability of primary care health databases to assess medicinal products discussed by the European Union Pharmacovigilance Risk Assessment Committee
Author(s): Robert Flynn1,2,*, Karin Hedenmalm1, Tarita Murray-Thomas3, Alexandra Pacurariu1, Peter Arlett1, Hilary Shepherd3, Puja Myles3, Xavier Kurz1
Affiliations(s): 1 Pharmacovigilance and Epidemiology Department, European Medicines Agency, Amsterdam, The Netherlands 2 Medicines Monitoring Unit (MEMO), Division of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom 3 Clinical Practice Research Datalink (CPRD), MHRA, London, United Kingdom
Publication(s):  First published: 18 January 2020 https://doi.org/10.1002/cpt.1775
Document Type(s): Abstract, Article,
Countries: France, Germany, UK,
Click here for the abstract
C:
Y:
Database Validity and methodology, Drug safety, Health policy,
2020
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Interventional or Non-Interventional? Analyzing the Differences Between Clinical Studies Using Medicines in the European Union
Author(s): Tiago Silva, MSc; Alexandra Parnell, MSc; Christopher Bamford, PhD; Catherine Paulen, PharmD; Simona Francisconi, MSc; Jaclyn Bosco, PhD, MPH; Louise Parmenter, PhD, MSc
Affiliations(s): 
Publication(s):  Clinical Researcher February 11, 2020
Clinical Trial Regulation (EU) No. 536/2014 (REG 536/2014
Document Type(s): Article, Online article,
Countries: Europe,
Click here for the abstract
C:
Y:
Clinical practice,
2020
  L:
A:
English
Population Based Study, Retrospective database analysis,
  Add to report
 
 
Modernizing Regulatory Evidence with Trials and Real-World Studies
Author(s): Nancy A. Dreyer PhD, MPH, FISPE, Marni Hall PhD, MPH & Jennifer B. Christian PharmD, MPH, PhD, FISPE
Affiliations(s): IQVIA Real World Solutions, 201 Broadway, 5th Floor, Cambridge, MA, 02139, USA Nancy A. Dreyer PhD, MPH, FISPE IQVIA Real-World Solutions, Rockville, MD, USA Marni Hall PhD, MPH IQVIA Real World Solutions, Research Triangle Park, NC, USA Jennifer B. Christian PharmD, MPH, PhD, FISPE
Publication(s):  Ther Innov Regul Sci (2020). https://doi.org/10.1007/s43441-020-00131-5
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Oncology,
2020
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Use of Low Density Lipoprotein-Lowering Therapies Before and After PCSK9 Inhibitors (PCSK9i) Initiation
Author(s): Rymer JA, Mues KE, Monda KL, Bratton EW, Wirtz HS, Okerson T, Overman RA, Brookhart MA, Muntner P, Wang TY
Affiliations(s): From the Duke Clinical Research InstituteDurham NC (J.A.R., T.Y.W.); Center for Observational ResearchAmgen IncThousand Oaks CA (K.E.M., K.L.M., H.S.W., T.O.); IQVIA, Real?World Evidence SolutionsDurham NC (E.W.B.); NoviSci, IncDurham NC (R.A.O., M.A.B.); University of North Carolina at Chapel HillChapel Hill NC (M.A.B.); Department of EpidemiologyUniversity of Alabama at BirminghamAL (P.M.).
Publication(s):  Originally published24 Apr 2020https://doi.org/10.1161/JAHA.119.014347Journal of the American Heart Association. ;0:e014347
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Cardiovascular disease, Medication compliance,
2020
  L:
A:
English
Epidemiological study,
  Add to report
 
 
The Burden Of Hpv In Head And Neck Cancers - Design Of The Broaden Study
Author(s): Gómez Ulloa D1, Morais E2, Fenoll R1, Kothari S3, Giuliano A4, Mirghani H5, Mehanna H6, Waterboer T7, Roberts C3, Varga S3, Tu Y3, Pérez G3, Saah A3, Alemany L8
Affiliations(s): 1 IQVIA, Barcelona, Spain 2 MSD, CORE, Lyon, France 3 Merck & Co. Inc., Center for Observational and Real-world Evidence, Kenilworth, NJ, US 4 Moffitt Cancer Center and Research Institute, Center for Immunization and Infection Research in Cancer, Tampa, FL, US 5 HEGP, ORL, Paris, France 6 InHANSE, Head and Neck Surgery, Birmingham, UK 7 German Cancer Research Center (DKFZ), Infections and Cancer Epidemiology, Heidelberg, Germany 8 Catalan Institute of Oncology - IDIBELL, On behalf of Unit of Cancer and Infection in the Cancer Epidemiology Research Programme, Hospitalet Del Llobregat, Spain
Publication(s):  IPVC, Barcelona, Spain, 23-27 March 2020
Document Type(s): Oral presentation,
Countries: China, France, Germany, Italy, Japan, Portugal, Spain,
C:
Y:
Infectious disease, Oncology,
2020
  L:
A:
English
Burden of illness, Observational study, Retrospective Field Study,
  Add to report
 
 
Clinical management of serious infections attributable to carbapenem-resistant Gram-negative pathogens in Spanish hospitals
Author(s): Ferrer R1, Calvo-Montes J2, Maseda E3, Salavert M4, Bou G5, Díaz-Regañón J6, López D6, Lozano V6, Gómez-Ulloa D7, Fenoll R7, Sánchez E7, McCann E8
Affiliations(s): 1 Vall d'Hebron University Hospital, Barcelona, Spain 2 Marqués de Valdecilla University Hospital, Santander, Spain 3 La Paz University Hospital, Madrid, Spain 4 La Fe University and Polytechnic Hospital, Valencia, Spain 5 La Coruña University Hospital, La Coruña, Spain, Spain 6 Merck Sharp & Dohme Corp., Madrid, Spain 7 IQVIA, Barcelona, Spain 8 Merck & Co., Inc., Kenilworth, NJ, US
Publication(s):  ECCMID, Paris, France, 18-21 April 2020
Document Type(s): Poster,
Countries: Spain,
C:
Y:
Infectious disease,
2020
  L:
A:
English
Observational study, Retrospective Field Study,
  Add to report
 
 
Real-world treatment patterns observed in patients with carbapenem-resistant Gram-negative infections in Italian hospitals
Author(s): Durante Mangoni E1, Mastroianni C2, Viale P3, Bassetti M4, Citton R5, Fenoll R6, Roset M6, McCann E7
Affiliations(s): 1 University of Campania ?L. Vanvitelli?, Monaldi Hospital, Naples, Italy 2 Policlinico Umberto I, Rome, Italy 3 AOU Policlinico S. Orsola-Malpighi, Bologna, Italy 4 University of Genova and Ospedale Policlinico San Martino, Genova, Italy 5 RC Merck Sharp & Dohme, Rome, Italy 6 IQVIA, Barcelona, Spain 7 Merck & Co., Inc., Kenilworth, NJ, US
Publication(s):  ECCMID, Paris, France, 18-21 April 2020
Document Type(s): Oral presentation,
Countries: Italy,
C:
Y:
Infectious disease,
2020
  L:
A:
English
Observational study, Retrospective Field Study,
  Add to report
 
 
Real-world treatment of patients diagnosed with serious infections due to carbapenem-resistant Gram-negative pathogens in Greek hospitals
Author(s): Georgopoulos D1, Safarika A2, Ischaki E3, Filiou E4, Mantzarlis K5, Athanasopoulos D6, Fenoll R7, Sánchez E7, McCann E8
Affiliations(s): 1 University Hospital of Crete, Crete, Greece 2 National and Kapodistrian University of Athens, Athens, Greece 3 General Hospital of Athens Evaggelismos, Athens, Greece 4 National and Kapodistrian University of Athens, Medical School, General Hospital for Chest Diseases 'I Sotiria? , Athens, Greece 5 University Hospital of Larissa, Larissa, Greece 6 Merck Sharp & Dohme Corp., Athens, Greece 7 IQVIA, Barcelona, Spain 8 Merck & Co., Inc., Kenilworth, NJ, US
Publication(s):  ECCMID, Paris, France, 18-21 April 2020
Document Type(s): Oral presentation,
Countries: Greece,
C:
Y:
Infectious disease,
2020
  L:
A:
English
Observational study, Retrospective Field Study,
  Add to report
 
 
Resource utilisation associated with infections attributable to carbapenem-resistant Gram-negative pathogens in southern European hospitals
Author(s): Durante Mangoni E1, Georgopoulos D2, Fernández-Martínez M3, Mastroianni C4, Viale P5, Bassetti M6, Ferrer R7, Giamarellos-Bourboulis E8, Maseda E9, Salavert M10, Perivoliotis E11 ,Bou Arevalo G12, Koutsoukou A13, Mantzarlis K14, Lozano V15, Gómez-Ulloa D16, Roset M16, McCann E17
Affiliations(s): 1 ‘L. Vanvitelli’ University, Monaldi Hospital, Naples, Italy 2 University Hospital of Crete, Crete, Greece 3 Marqués de Valdecilla University Hospital, Santander, Spain 4 Policlinico Umberto I, Rome, Italy 5 Policlinico S. Orsola-Malpighi, Bologna, Italy 6 University of Genova and Policlinico San Martino, Genova, Italy 7 Vall d'Hebron University Hospital, Barcelona, Spain 8 National and Kapodistrian University of Athens, Athens, Greece 9 University Hospital La Paz, Madrid, Spain 10 Hospital Universitario y Politécnico de La Fe, València, Spain 11 Evaggelismos General Hospital, Athens, Greece 12 Hospital Universitario La Coruña, La Coruña, Spain 13 National and Kapodistrian University and General Hospital for Chest Diseases 'I Sotiria’ , Athens, Greece 14 University Hospital of Larissa, Larisa, Greece 15 Merck Sharp & Dohme, Madrid, Spain 16 IQVIA, Barcelona, Spain 17 Merck & Co., Inc., Kenilworth, NJ, US
Publication(s):  ECCMID, Paris, France, 18-21 April 2020
Document Type(s): Oral presentation,
Countries: Greece, Italy, Spain,
C:
Y:
Infectious disease,
2020
  L:
A:
English
Observational study, Retrospective Field Study,
  Add to report
 
 
Outcomes and predictors of outcomes of serious infections attributable to carbapenem-resistant Gram-negative pathogens in southern European hospitals
Author(s): Georgopoulos D1, Durante Mangoni E2, Mastroianni C3, Viale P4, Arnáiz de las Revillas F5, Bassetti M6, Ferrer R7, Giamarellos-Bourboulis E8, Maseda E9, Salavert M10, Malachias S11, Bou Arevalo G12, Kyriakoudi A13, Tsolaki V14, Lopez D15, Gómez-Ulloa D16, Lara N16, McCann E17
Affiliations(s): 1 University Hospital of Crete, Crete, Greece 2 ‘L. Vanvitelli’, Monaldi Hospital, Naples, Italy 3 Policlinico Umberto I, Rome, Italy 4 Policlinico S. Orsola-Malpighi, Bologna, Italy 5 Marqués de Valdecilla University Hospital, Santander, Spain 6University of Genova and Policlinico San Martino, Genova, Italy 7 Vall d'Hebron University Hospital, Barcelona, Spain 8 National and Kapodistrian University of Athens, Athens, Greece 9 University Hospital La Paz, Madrid, Spain 10 Hospital Universitario y Politécnico de La Fe, València, Spain 11 Evaggelismos General Hospital, Athens, Greece 12 Hospital Universitario La Coruña, La Coruña, Spain 13 National and Kapodistrian University and General Hospital for Chest Diseases 'I Sotiria’, Athens, Greece 14 University Hospital of Larissa, Larisa, Greece 15 Merck Sharp & Dohme, Madrid, Spain 16 IQVIA, Barcelona, Spain 17 Merck & Co., Inc., Kenilworth, NJ, US
Publication(s):  ECCMID, Paris, France, 18-21 April 2020
Document Type(s): Oral presentation,
Countries: Greece, Italy, Spain,
C:
Y:
Infectious disease,
2020
  L:
A:
English
Observational study, Retrospective Field Study,
  Add to report
 
 
 1 of 408 Next Page Last Page